Philadelphia-based Noble.MD, which has developed a patient health risk assessment tool, raised $1.45 million from Safeguard Scientifics and BioAdvance to launch two new products.
“We have been helping our clients build their patient-reported population health databases for years,” Noble.MD CEO Dr. Todd Johnson said in a statement. “Now we are using that expertise to help our clients directly and...
